decentralized clinical trials

At the 2024 DPHARM conference, Ken Getz, Executive Director and Research Professor at Tufts Center for the Study of...

Walgreens and the Biomedical Advanced Research and Development Authority (BARDA) have joined forces to enhance decentralized clinical trials through...

The 2024 DIA conference session on decentralized clinical trials (DCTs) brought together leading experts from various sectors to discuss...

In recent years, clinical trials have transformed with the rise of decentralized clinical trials (DCTs). This innovative approach leverages...

Decentralized Clinical Trials (DCTs) are revolutionizing clinical research, offering potential improvements in trial efficiency and participant diversity. In a...

The 2024 SCOPE Summit, a pivotal event in clinical trials, showcased innovative strategies to transform patient recruitment and trial...

In a recent webinar, industry luminaries including Harpreet Gill from ICON plc, Jane Twitchen from Biogen, Angela May from...

Decentralized clinical trials are at a pivotal juncture, shaped by technological advancements and evolving regulatory landscapes. While traditional clinical...

As the clinical trials industry embraces change, Decentralized Clinical Trials (DCTs) are emerging as the next significant evolution. Marrying...

Decentralized clinical trials (DCTs) are revolutionizing the landscape of clinical research. As the FDA navigates this shift, the Decentralized...